Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Aerovate Therapeutics Q3 Earnings

Aerovate Therapeutics (NASDAQ:AVTE) reported its Q3 earnings results on Monday, November 13, 2023 at 08:00 AM. Here’s what…
byBenzinga Insights
November 13, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aerovate Therapeutics (NASDAQ:AVTE) reported its Q3 earnings results on Monday, November 13, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aerovate Therapeutics missed estimated earnings by 2.9%, reporting an EPS of $-0.71 versus an estimate of $-0.69.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 1.14% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Aerovate Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For Asana

By Benzinga Insights
September 6, 10:08 AM
Asana (NYSE:ASAN) is set to give its latest quarterly earnings report on Wednesday, 2022-09-07. Here's what investors need to know before the announcement. Analysts estimate that Asana will report an earnings per share (EPS) of $-0.39.

ASAN

Read More

Sarepta Therapeutics Earnings Preview

By Benzinga Insights
August 1, 10:26 AM
Sarepta Therapeutics (NASDAQ:SRPT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Sarepta Therapeutics will report an earnings per share (EPS) of $-1.18.

SRPT